Literature DB >> 7642633

A TATA-less promoter containing binding sites for ubiquitous transcription factors mediates cell type-specific regulation of the gene for transcription enhancer factor-1 (TEF-1).

D S Boam1, I Davidson, P Chambon.   

Abstract

TEF-1 is a tissue-specific human transcription factor which binds to and activates transcription from the SV40 early promoter and the HPV-16 E6/E7 promoter and may be involved in regulation of muscle-specific and placenta-specific gene expression. To investigate the mechanism of its tissue-specific expression, we have isolated up to 3 kilobase pairs of 5'-flanking DNA and characterized the promoter of the gene for TEF-1. Multiple transcription start sites centering on a motif similar to the initiator element (Inr) were identified. A minimal promoter, which contains no recognizable TATA element but contains an Inr, delimited at -137 base pairs had full transcriptional activity both in vivo in HeLa cells and in vitro in HeLa cell extracts. This promoter is also highly active in vitro in lymphoid cell extracts, but not in vivo in lymphoid cell lines, which do not express the endogenous TEF-1 gene. The minimal promoter, which is sufficient to direct tissue-specific expression of the TEF-1 gene in vivo, contains multiple sites which bind the ubiquitous transcription factors Sp1 and ATF-1. Mutation of the Inr completely abolished transcription from the major start site while transcription from the minor sites was slightly augmented. Inactivation of the proximal Sp1 site abolished transcription from the principle start site and increased transcription from a 5' minor start site. Insertion of a TATA box element did not qualitatively alter the pattern of start site usage which seemed to be dependent upon integrity of the upstream Sp1 site. These observations suggest a "cross-talk" between the Inr and a proximal element to fix transcription start sites, which is independent of spacing and the presence of a TATA element.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7642633     DOI: 10.1074/jbc.270.33.19487

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivity.

Authors:  Jianguo Wu; Xiang Ling; Dalin Pan; Pasha Apontes; Lei Song; Ping Liang; Dario C Altieri; Terry Beerman; Fengzhi Li
Journal:  J Biol Chem       Date:  2005-01-05       Impact factor: 5.157

2.  A minimal regulatory region maintains constitutive expression of the max gene.

Authors:  M A Peters; K G Sollenberger; T L Kao; E J Taparowsky
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

3.  DNA-binding activity of the transcription factor upstream stimulatory factor 1 (USF-1) is regulated by cyclin-dependent phosphorylation.

Authors:  E Cheung; P Mayr; F Coda-Zabetta; P G Woodman; D S Boam
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

4.  SP1 is a transcriptional regulator of URG-4/URGCP gene in hepatocytes.

Authors:  Esra Tokay; Feray Kockar
Journal:  Mol Cell Biochem       Date:  2016-10-20       Impact factor: 3.396

5.  A TEF-1-element is required for activation of the promoter of pseudorabies virus glycoprotein X gene by IE180.

Authors:  Chia-Jen Ou; Min-Liang Wong; Tien-Jye Chang
Journal:  Virus Genes       Date:  2002-12       Impact factor: 2.332

6.  Sp1 and Sp3 regulate transcription of the cyclin-dependent kinase 5 regulatory subunit 2 (p39) promoter in neuronal cells.

Authors:  Alvaro Valin; Julie D Cook; Sarah Ross; Christi L Saklad; Grace Gill
Journal:  Biochim Biophys Acta       Date:  2009-03

7.  Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene.

Authors:  Mika Yoshida; Yorifumi Satou; Jun-Ichirou Yasunaga; Jun-Ichi Fujisawa; Masao Matsuoka
Journal:  J Virol       Date:  2008-07-23       Impact factor: 5.103

Review 8.  Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns.

Authors:  Nikita Aggarwal; Joni Yadav; Kulbhushan Thakur; Rakhi Bibban; Arun Chhokar; Tanya Tripathi; Anjali Bhat; Tejveer Singh; Mohit Jadli; Ujala Singh; Manoj K Kashyap; Alok C Bharti
Journal:  Front Cell Infect Microbiol       Date:  2020-12-02       Impact factor: 5.293

Review 9.  The Role of HBZ in HTLV-1-Induced Oncogenesis.

Authors:  Tiejun Zhao
Journal:  Viruses       Date:  2016-02-02       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.